The frequency of EBV epitope-specific CTL in peripheral blood
| Donor | EBV Epitope | LDAa | ELISPOTa | Tetramerab |
|---|---|---|---|---|
| CH | B8 RAKFKQLL | 60 | 1,020 | 2,605 (1.0%) |
| B8 FLRGRAYGL | 21 | 121 | 230 (0.1%) | |
| PA | B8 RAKFKQLL | 125 | 295 | 177 (0.1%) |
| B8 FLRGRAYGL | Undetectable | Undetectable | Undetectable | |
| B7 RPPIFIRRL | 20 | 165 | ND | |
| JB | B8 RAKFKQLL | NDc | 750 | 7,000 (5.0%) |
| B8 FLRGRAYGL | ND | 480 | 2,900 (2.0%) | |
| AR | B8 RAKFKQLL | ND | 250 | 1,600 (0.5%) |
| B8 FLRGRAYGL | ND | 460 | 2,100 (0.7%) | |
| CM | B8 RAKFKQLL | 725 | 2,300 | 6,200 (4.3%) |
| B8 FLRGRAYGL | Undetectable | 10 | Undetectable | |
| A11 IVTDFSVIK | 240 | 810 | 4,760 (3.3%) | |
| A11 AVFDRKSDAK | 25 | 400 | ND | |
| DM | B8 RAKFKQLL | ND | 2,500 | 11,400 (5.5%) |
| B8 FLRGRAYGL | ND | 20 | Undetectable | |
| A11 IVTDFSVIK | 170 | 1,000 | 5,000 (3.8%) | |
| A11 AVFDRKSDAK | 10 | 120 | ND | |
| LU | B8 RAKFKQLL | 60 | 350 | ND |
| B8 FLRGRAYGL | 40 | 165 | ND | |
| A2 GLCTLVAML | 15 | t 25 | ND | |
| JS | A2 GLCTLVAML | 130 | 710 | 2,900 (0.8%) |
| VN | A2 GLCTLVAML | 380 | 710 | 2,600 (1.1%) |
| A2 SVRDRLARL | ND | 95 | ND | |
| RO | A2 GLCTLVAML | 10 | 15 | Undetectable |
| A2 SVRDRLARL | ND | 10 | ND | |
| B7 RPPIFIRRL | 175 | 430 | ND | |
| LC | A2 GLCTLVAML | 135 | 360 | 920 (0.4%) |
| A11 IVTDFSVIK | Undetectable | Undetectable | ND | |
| DA | A11 IVTDFSVIK | ND | 500 | 2,000 (1.6%) |
| A11 AVFDRKSDAK | ND | 50 | ND | |
| PB | A11 IVTDFSVIK | 40 | 300 | 1,800 (0.7%) |
| A11 AVFDRKSDAK | Undetectable | 70 | ND |
a Values are given per 106 PBMC.
b Values in parentheses are given as % CD8+ T cells.
c ND, not determined.